Baxter Aktiengesellschaft
71Patents
4Active
71Granted
39Portfolio score
Filing activity: May 30, 1978 → Feb 4, 2011 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6146873A | Production of orthomyxoviruses in monkey kidney cells using protein-free media | Chemistry; Metallurgy | 88 | Expired |
| US6936441B2 | Recombinant cell clones having increased stability and methods of making and using the same | Chemistry; Metallurgy | 87 | Expired |
| US6224862A | Pharmaceutical preparation for treating blood coagulation disorders | Chemistry; Metallurgy | 74 | Expired |
| US6017891A | Stable preparation for the treatment of blood coagulation disorders | Chemistry; Metallurgy | 62 | Expired |
| US6475725B1 | Recombinant cell clones having increased stability and methods of making and using the same | Chemistry; Metallurgy | 60 | Expired |
| US6649162B1 | Hemostatic sponge based on collagen | Emerging Cross-Sectional Technologies | 59 | Expired |
| US6620125B1 | Method and device for mixing and applying components of differing viscosities | Human Necessities | 56 | Expired |
| US6114146A | Expression plasmid, a fusion protein, a transfected eukaryotic cell line, a method of producing foreign proteins, a foreign protein preparation as well as a pharmaceutical composition | Chemistry; Metallurgy | 49 | Expired |
| US6548729B1 | Fibrin sponge | Human Necessities | 42 | Expired |
| US6013620A | Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use | Chemistry; Metallurgy | 41 | Expired |
| US6372223B1 | Influenza virus vaccine composition | Chemistry; Metallurgy | 35 | Expired |
| US7033590B1 | Factor IX/factor IXa activating antibodies and antibody derivatives | Human Necessities | 34 | Expired |
| US6136321A | Method of inactivating lipid-enveloped viruses | Chemistry; Metallurgy | 32 | Expired |
| US7220569B2 | Nucleic acids encoding factor X analogues having a modified protease cleavage site | Human Necessities | 29 | Expired |
| US6228613A | Stable factor VIII/von Willebrand factor complex | Emerging Cross-Sectional Technologies | 24 | Expired |
| US7094574B2 | Recombinant cell clones having increased stability and methods of making and using the same | Chemistry; Metallurgy | 21 | Expired |
| US6270672A | Devices and methods for removing pathogens from biological fluids | Performing Operations; Transporting | 20 | Expired |
| US6086871A | Prothrombin derivatives | Physics | 20 | Expired |
| US6926894B2 | Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV | Chemistry; Metallurgy | 19 | Expired |
| US6210929A | Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequence | Chemistry; Metallurgy | 19 | Expired |
| US6573071B1 | Factor X analogues with a modified protease cleavage site | Human Necessities | 17 | Expired |
| US6579723B1 | Method of recovering highly purified vWF or factor VIII/vWF-complex | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6358534B1 | Immunotolerant prothrombin complex preparation | Human Necessities | 15 | Expired |
| US6579537B2 | Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or &bgr;-alanine | Chemistry; Metallurgy | 15 | Expired |
| US6562598B1 | Factor X deletion mutants and analogues thereof | Human Necessities | 15 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.